DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Soufflet N, Boschetti G, Roblin X. et al.
Concentrations of ustekinumab during induction therapy associate with remission in patients with Crohn’s disease.
Clin Gastroenterol Hepatol 2019;
17: 2610-2612
We do not assume any responsibility for the contents of the web pages of other providers.